Subacute inflammatory demyelinating polyneuropathy

Subacute inflammatory demyelinating polyneuropathy (SIDP) is a rare immune-mediated peripheral nerve disorder that represents an intermediate form between acute inflammatory demyelinating polyneuropathy (AIDP, also known as Guillain-Barré syndrome) and chronic inflammatory demyelinating polyneuropathy (CIDP). It is characterized by progressive or relapsing weakness and sensory disturbances in the limbs that develop over a subacute time course, typically between 4 and 8 weeks from symptom onset. This distinguishes it from AIDP, which reaches its nadir within 4 weeks, and CIDP, which progresses beyond 8 weeks. The disease primarily affects the peripheral nervous system, where an aberrant immune response targets the myelin sheath surrounding peripheral nerves. This demyelination leads to impaired nerve signal conduction, resulting in symmetrical proximal and distal muscle weakness, reduced or absent deep tendon reflexes (hyporeflexia or areflexia), sensory loss including numbness and tingling (paresthesias), and sometimes neuropathic pain. Patients may experience difficulty walking, impaired fine motor skills, and fatigue. Cranial nerves may occasionally be involved. Electrodiagnostic studies typically reveal features of demyelination, and cerebrospinal fluid analysis often shows elevated protein with a normal cell count (albuminocytologic dissociation). Treatment for SIDP is similar to that used for CIDP and includes immunomodulatory therapies such as intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and corticosteroids. Many patients respond favorably to these treatments, though some may experience relapses and require long-term immunosuppressive therapy. The prognosis is generally considered better than that of CIDP, with some patients achieving full or near-complete recovery, particularly with early and appropriate treatment. Close neurological follow-up is important to monitor for progression to a chronic course.

Common questions about Subacute inflammatory demyelinating polyneuropathy